Disopyramide labels and packages

Revision as of 04:33, 3 March 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Disopyramide}} {{CMG}}; {{AE}} {{SS}} ==Labels and Packages== {| |thumb|800px |} {| |thumb|800px |} {| ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Disopyramide
NORPACE® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Disopyramide
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels and Packages

[1]


References

  1. ↑ "NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]". Retrieved 3 March 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Disopyramide_labels_and_packages&oldid=949621"